Post-COVID-19 cardiac scarring and inflammation are common

  • JAMA Cardiol

  • curated by Emily Willingham, PhD
  • Clinical Essentials
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Almost 8 in 10 patients who have “recovered” from COVID-19 have cardiac involvement on cardiac magnetic resonance imaging (CMR).
  • 60% showed signs of myocardial inflammation in this German cohort study.
  • Signs seen regardless of preexisting conditions, COVID-19 severity, or course.

Why this matters

  • Patients with a history of COVID-19 may need close cardiovascular follow-up.
  • Editorial notes findings in accompanying autopsy study, with evidence of the virus in the heart in 24/39 patients, along with evidence of viral replication.
  • Editorial: accumulating results “raise a new and very evident concern that cardiomyopathy and heart failure related to COVID-19 may potentially evolve as the natural history of this infection becomes clearer.”

Key results

  • Among 100 recovered patients (47% female; median age, 49 years; interquartile range, 45-53 years):
    • 33% had been hospitalized.
    • Only 1 had been treated with hydrochloroquine, which was discontinued.
  • At time of CMR, 17% had chest pain, 20% had palpitations, 36% had dyspnea.
  • 71% had detectable high-sensitivity troponin T, and 5% had significantly elevated values.
  • On CMR, 78% had abnormal cardiac findings.
  • Most informative CMR findings for COVID-19 cardiac pathology were increased native T1 and T2.

Study design

  • Prospective observational cohort study, University Hospital Frankfurt COVID-19 Registry, April-June 2020.
  • For some analyses, patients were age- and sex-matched to healthy volunteers (n=50) and risk-factor-matched patients (n=57).
  • Funding: German Ministry of Education and Research; others.

Limitations

  • No pediatric patients.
  • No truly asymptomatic cases.
  • Outcomes pending.